All News
How Should Patients With Autoimmune Diseases Approach COVID Vaccination?
d
MedPage Today
Healthcare is a personal and individualized relationship between a provider and patient. Each patient is treated according to their particular symptoms and personal health characteristics.
Read Article
Increased Preterm Birth Risk in Psoriatic Arthritis Pregnancies
Pregnancy outcomes may be affected by psoriatic arthritis or antirheumatic treatment; registry cohort study shows that preterm birth and cesarean delivery were mostly increased by antirheumatic treatment, especially biologics.
Read Article
83 patients w/ ANCA Assoc. Vasculitis, hospital admited, 44 died in-ICU (53%) w/ death by infection (61%), active vasculitis (34%). Predictors of ICU death were APACHE II score (OR=1.3) and respiratory failure (OR=620). https://t.co/ZPBkVWy40I
Links:
Dr. John Cush RheumNow ( View Tweet)
Among 825,556 sepsis pts in Taiwan (2003–2017), having SLE increased mortality risk 3 fold (HR 2.8;2.5–3.2), w/ adjustments (HR 1.47). Other risk factors: age (1.02), prednisolone > 5mg/d (1.55), MTX (2.19) & immunosuppressives (1.45) https://t.co/d1OPrjgshz
Links:
Dr. John Cush RheumNow ( View Tweet)
Israeli study of 1497 fully vaccinated health care workers finds 39 (2.4% Breakthrough COVID infections (Jan-May 2021), most cases were mild or asymptomatic, 19% w/ persistent Sxs (>6 ws); infected had lower neutralizing Abs. https://t.co/deYTVLRQCU
Links:
Dr. John Cush RheumNow ( View Tweet)
ATOM study - Phase 3 RCT testing abaloparatide (Tymlos) in 228 men with osteoporosis. At 12 mos Tymlos shows signif increase in lumbar BMD of 1.2%. Also increased were hip and femoral neck BMD at 12 months. https://t.co/WC3ygkyMZH
Links:
Dr. John Cush RheumNow ( View Tweet)
ICYMI: In a real world study of lupus patients, aspirin use lowered risk of preeclampsia, as did hydroxychloroquine. Risk Factors for preeclampsia were high Dz activity 1st trimester(OR 4.55),BMI >30 (6.14),antiphospholipid synd (8.02),hx preeclampsia (9.8)https://t.co/giBamMAPRM https://t.co/NHKxlmEHQj
Links:
Dr. John Cush RheumNow ( View Tweet)
Rheumatologist Smoke-Enders available for download wherever you get your podcasts.
https://t.co/o35tuNgk8R https://t.co/pksojrC5Wb
Links:
Dr. John Cush RheumNow ( View Tweet)
"Progress is a nice word. But change is its motivator and change has its enemies."
- Robert F. Kennedy https://t.co/sIVym3e80c
Dr. John Cush RheumNow ( View Tweet)
ICYMI: Nice full read review of IL-23 in Rheumatology - its biology and clinical targeting. IL-23 is a coordinating cytokine in psoriasis, psoriatic arthritis and inflammatory bowel disease. https://t.co/tDWZuV6Tao https://t.co/0p8RGnnE9B
Links:
Dr. John Cush RheumNow ( View Tweet)
ICYMI: Propensity matched comparison of Tramadol vs Codeine use. Tramadol had a signif. higher risk of all-cause mortality (HR, 2.31), CV events (HR 1.15) & fractures (HR 1.50), but no diff in falls, delirium, constipation, opioid abuse, sleep disorders. https://t.co/nBUe5VV1D3 https://t.co/C3r0Fur4xJ
Links:
Dr. John Cush RheumNow ( View Tweet)
Congratulations to friend and mentor, Dr. Stan Cohen for receiving this years ACR Gold Medal award - the highest award that the ACR can bestow. Stan was a past ACR President & has been a leading educator and researcher in rheumatology https://t.co/EJQ5tc3dhc
Links:
Dr. John Cush RheumNow ( View Tweet)
ICYMI:Pregabalin (lyrica) for Fibromyalgia 75 mg bid; may be increased to max dose 450 mg/d.(Reduce for renal dz). Indications: DM neuropathy/pain, post-herpetic neuralgia, partial seizures. Rare AE: Angioedema, low Plts, ^PR interval, rhabdo, gynecomastia https://t.co/r4cH7n9qWD
Links:
Dr. John Cush RheumNow ( View Tweet)
ICYMI: B-cell depletion therapy with obinutuzumab, a type II anti-CD20 monoclonal antibody, in lupus nephritis patients was shown to be effective in in combination with standard lupus therapies.
https://t.co/pMXWmuJw5Y https://t.co/RhWdVir6yB
Links:
Dr. John Cush RheumNow ( View Tweet)
ICYMI: FDA Approves Cyltezo, the 1st INTERCHANGEABLE Biosimilar to Humira - interchangeable means this biosimilar may be substituted for the Humira without the prescriber notice (by pharmacy)in same way generics are substituted for brand name drugs https://t.co/xvinL7UKNU https://t.co/8y5asZ7NWq
Links:
Dr. John Cush RheumNow ( View Tweet)
New podcast up! Rheumatologist Smoke-Enders
https://t.co/o35tuNgk8R https://t.co/iEqVoggl32
Links:
Dr. John Cush RheumNow ( View Tweet)
Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Insights
Read the full article on #RheumNow
https://t.co/294Au0Q1c3 https://t.co/c1X2T5G4jW
Links:
Dr. John Cush RheumNow ( View Tweet)
RECOVERY study of hospitalized COVID-19 pts compared colchicine to PBO (+usual care). Colchicine had no effect on 28d mortality (21% vs 21%), time to D/C(10 d vs 10d), LIve D/C (70 vs 70%), mechanical vent or death (25 vs 25%) https://t.co/dYZglKzwxC
Links:
Dr. John Cush RheumNow ( View Tweet)
Nice full read review of IL-23 in Rheumatology - its biology and clinical targeting. IL-23 is a coordinating cytokine in psoriasis, psoriatic arthritis and inflammatory bowel disease. https://t.co/tDWZuV6Tao
Links:
Dr. John Cush RheumNow ( View Tweet)
Propensity matched comparison of Tramadol vs Codeine use. Tramadol had a signif. higher risk of all-cause mortality (HR, 2.31), CV events (HR 1.15) & fractures (HR 1.50), but no diff in falls, delirium, constipation, opioid abuse, sleep disorders. https://t.co/nBUe5VV1D3 https://t.co/DHzrXQ2nr1
Links:
Dr. John Cush RheumNow ( View Tweet)